Close
RNS Number : 9275Q
Induction Healthcare Group PLC
24 October 2019
 

24 October 2019

 

Induction Healthcare Group PLC

 

("Induction", the "Company" or the "Group")

 

Appointment of Dr Hugo Stephenson as acting Head of Product/Development

 

Induction Healthcare Group PLC, a leading healthcare technology company helping to streamline the delivery of care, announces that, to cover for ill health, Dr. Hugo Stephenson, Non-Executive Director, has taken up the role of interim Head of Product/Development.

 

Hugo is a technology entrepreneur and a practicing doctor in Australia. He is co-founder of Induction Healthcare and has a combination of healthcare and technology experience including as executive chairman and co-founder of DrugDev and Vice President at Quintiles.

 

The Board has approved this temporary management change to ensure continued effective operational performance pending the leadership of product/development being fulfilled internally or externally in relation to which a process is already underway.  

 

-Ends-

 

ENQUIRIES

 

Induction Healthcare Group PLC

Ibs Mahmood, Chief Executive Officer

 

via FTI Consulting

Numis Securities (Nominated Adviser and Broker)

James Black / Freddie Barnfield / Huw Jeremy / Matthew Jones

 

+44 (0) 207 260 1000

FTI Consulting

Brett Pollard / Jamie Ricketts / Elena Kalinskaya / Sam Purewal

+44 (0) 203 727 1000

 

 

About Induction

Induction Healthcare Group PLC is a leading healthcare technology company focused on helping healthcare professionals to streamline the delivery of care. The Group's technology enables healthcare professionals to save time and deliver care more effectively and to identify ways to allocate resources more efficiently.

 

The Group is initially targeting improving the way healthcare professionals communicate with each other through its Induction Switch app that provides a telephone directory (allowing healthcare professionals to easily find extension telephone numbers), messaging and an administration portal (to share and view hospital guidelines), all in a secure and regulatory compliant setting.

 

As at 19 September 2019, the Induction Switch app had registered users surpassing 100,000, most of which are UK hospital doctors.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAKEDAFFNFFF